With the Paris 2024 Olympics on the horizon, anti-doping testing is a key focus. In this upcoming SelectScience® webinar, Gabe Baida of InnoVero will discuss the current testing landscape and new, athlete-centric innovations that are advancing the field. Register here: https://lnkd.in/eKBaxsNY #antidoping #cleansport #patientcentric
Tasso, Inc.
Biotechnology
Seattle, Washington 7,784 followers
Life-changing, actionable insights. We are revolutionizing blood collection.
About us
Tasso is a fast-growing Seattle-based startup focused on delivering at-home diagnostic testing to those who need it most. We are growing our footprint with leading health systems, clinical research organizations, academic medical centers, and more who are looking to deliver clinical-grade, convenient diagnostic tests to their patients. Tasso was originally founded to find a better way to collect blood instead of a painful fingerstick or time-consuming venous draw. Since then, our products have been used in pharmaceutical clinical trials, by Olympians as part of a new virtual anti-doping program, and broadly by hospital systems across the US.
- Website
-
http://www.tassoinc.com
External link for Tasso, Inc.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Seattle, Washington
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Diagnostics, Medical Manufacturing, BioTech, Healthcare, and Medical Devices
Locations
-
Primary
1631 15th Ave W
Suite 105
Seattle, Washington 98119, US
Employees at Tasso, Inc.
Updates
-
Tasso is pleased to announce the extension of our partnership with InnoVero to provide athlete-centric testing solutions. Learn more in the press release here: https://lnkd.in/gvhzv3BG #antidoping #cleansport #patientcentric Gabe Baida
-
Congratulations to our partner Artyc on winning Best in Show at the DIA Annual Meeting! https://lnkd.in/g-2QNpfx #DIA2024
Huge congratulations to our winning #DIA2024 Best in Show exhibitor, Artyc, for showcasing their impressive Medstow Micro microsample shipper🌟 Thank you to all voting attendees and participating exhibitors!
-
Sneak preview! Our CEO Ben Casavant was interviewed today at the DIA Annual Meeting about how decentralized blood collection is making a difference for patients. Look for the segment next week on The LOCAList SD, FOX 5 San Diego & KUSI News. #DIA2024 #pharmaceuticals #clinicaltrials
-
The DIA Annual Meeting exhibit hall opens in just one week. We look forward to meeting with you at booth 2427! #DIA2024 #pharmaceuticals #clinicaltrials Ryan Asplund Bobby Virasingh
-
Learn more about how patient centricity can benefit clinical trials in the latest episode of Karen Jagoda's Empowered Patient Podcast, featuring Tasso's CEO Ben Casavant. The podcast and transcript are available here: https://lnkd.in/ewzy5pb7 #clinicaltrials #healthtech #pharmaceuticals
-
Tasso is pleased to announce our collaboration with Lindus Health to reduce patient burden in clinical trials. Learn more in the press release here: https://lnkd.in/g6M97_i7 #clinicaltrials #decentralizedclinicaltrials #patientcentric
-
Tasso is pleased to announce our partnership with The Leukemia & Lymphoma Society. Learn more about our clinical trial collaboration in the press release here: https://lnkd.in/gu7WwTWs #cancerresearch #clinicalresearch #clinicaltrials
-
Tasso will be exhibiting at the DIA Annual Meeting next month. Visit us at booth 2427 throughout the conference, or contact us to reserve a consultation. www.tassoinc.com/contact #DIA2024 #pharmaceuticals #clinicaltrials Ryan Asplund Bobby Virasingh
CONTACT — Tasso, Inc.
tassoinc.com
-
Tasso has partnered with the Parkinson's Foundation to advance Parkinson's Disease research and expand patient access. Learn more about the impact of our groundbreaking partnership in this NeurologyLive video interview. https://lnkd.in/gv9yWWgt #parkinsonsdisease #clinicalresearch #research
Using a Blood Collection Device to Advance Genetic Research in Parkinson Disease: James Beck, PhD & Ben Casavant, PhD
neurologylive.com